| Literature DB >> 21880743 |
Ravi Tandon1, Devi SenGupta, Lishomwa C Ndhlovu, Raphaella G S Vieira, R Brad Jones, Vanessa A York, Vinicius A Vieira, Elizabeth R Sharp, Andrew A Wiznia, Mario A Ostrowski, Michael G Rosenberg, Douglas F Nixon.
Abstract
Human endogenous retrovirus (HERV)-specific T cell responses in HIV-1-infected adults have been reported. Whether HERV-specific immunity exists in vertically HIV-1-infected children is unknown. We performed a cross-sectional analysis of HERV-specific T cell responses in 42 vertically HIV-1-infected children. HERV (-H, -K, and -L family)-specific T cell responses were identified in 26 of 42 subjects, with the greatest magnitude observed for the responses to HERV-L. These HERV-specific T cell responses were inversely correlated with the HIV-1 plasma viral load and positively correlated with CD4(+) T cell counts. These data indicate that HERV-specific T cells may participate in controlling HIV-1 replication and that certain highly conserved HERV-derived proteins may serve as promising therapeutic vaccine targets in HIV-1-infected children.Entities:
Mesh:
Year: 2011 PMID: 21880743 PMCID: PMC3194955 DOI: 10.1128/JVI.05418-11
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103